Bristol-Myers Squibb appoints new chief financial officer

Bristol-Myers Squibb’s board of directors has selected Charles Bancroft to become the health care firm’s permanent chief financial officer (CFO), effective as of April 8th 2010.

Mr Bancroft has been employed by the biopharmaceutical company since 1984 and has occupied the role of acting CFO since the beginning of this year.

He will now become the full-time occupant of the role vacated by Jean-Marc Hulet on December 31st 2010, taking responsibility for the direction and management of the company’s fiscal operations.

As CFO, Mr Bancroft will report directly to president, chief operating officer and chief executive officer designate Lamberto Andreotti.

Commenting on the appointment, Mr Andreotti expressed confidence that Mr Bancroft will help to provide stable financial leadership and deliver value for shareholders.

He added: “His tenure with Bristol-Myers Squibb has been marked by strong leadership and depth of experience in finance, earning him trust and respect from his peers.”